Skip to main content

Mckesson Medical-Surgical Inc. Corporate Office

5 ongoing recalls and 152 historical records

Based on the official records currently available to Public Health Trace, 5 recalls naming Mckesson Medical-Surgical Inc. Corporate Office are currently shown as ongoing. The other 152 records below are historical.

Public Health Trace has 157 recalls naming Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm, republished from official FDA and USDA sources.

Recall records - 157 total

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
202290
20245
20255
Download CSV

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Ciprofloxacin Ophthalmic Solution 0.3%, 10 mL bottle, Rx only, Manufactured by: Alcon Laboratories, Inc., NDC 61314-0656-10

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Betamethasone Dipropionate Cream USP, 0.05%, 45 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0055-46

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Aparaclonidine Ophthalmic Solution 0.5% as base, 0.5%, 5 mL bottle, Rx only, MFG:Sandoz Pharma, NDC 61314-665-05

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Amoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0781-2613-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Albuterol Sulfate Inhalation Aerosol HFA 90 mcg, with Dose Indicator, 200 metered inhalations, Rx only, Distributed by: Sandoz Inc., NDC 0781-7296-85

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Albuterol Sulfate Inhalation Aerosol HFA with Dose Indicator, 90 mcg, 200 metered inhalations, Rx only, Manufactured for: PAR Pharmaceutical, NDC 0254-1007-52

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass III

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-count (NDC 0487-0201-03), b) 60-count (NDC 0487-0201-60), Rx only, MFG: Nephron Pharma

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 25 X 3mL unit-dose vials, Rx only, MFG by: Nephron Pharma, NDC 0487-9501-25

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 5 x 3 mL unit-dose vials, Rx only, Manufactured by: Nephron Pharma, NDC 0487-9501-03

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Albuterol Sulfate Inhalation Solution, 0.021%, 0.63 mg/3mL, packaged in 30 x 3 mL Sterile Unit-Dose Vials, Rx only, MFG: Nephron Pharma, NDC 0487-0301-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.